3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasmRecruitingPhase 32026-09-23NCT07252232
Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation TherapyChronic Pain, Intractable Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and SymptomsRecruitingNot stated2026-09-03NCT07507422
A Non-interventional Cohort Safety Study of Patients With hATTR-PNNutritional and Metabolic Diseases, amyloidosis, familial amyloid neuropathy, metabolic disease, proteostasis deficienciesActive, not recruitingNot stated2026-07-29NCT04850105